Brief: Orthocell Submits Regulatory Application To Commence Sales Of Remplir In Hong Kong
10/04/2025 02:28
April 10 (Reuters) - Orthocell Ltd OCC.AX: SUBMITS REGULATORY APPLICATION TO COMMENCE SALES OF REMPLIR IN HONG KONG Source text: ID:nASX4CpYkC Further company coverage: OCC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense